Manufacturer
ELI LILLY & CO
Contents
30% regular human insulin inj & 70% NPH human insulin isophane susp
Indication
Diabetes mellitus
Instruction
Administered via Subcutaneous.May be used alone or in combination with a fast-acting insulin.
Drug interaction
Concurrent use with oral antidiabetic agents, MAOIs, ACE inhibitors, salicylates, alcohol, anabolic steroids and non-selective β-blockers may reduce insulin requirements. Drugs that may increase insulin requirements include: Oral contraceptives, thiazides, thyroid hormones, growth hormone, danazol and β-sympathomimetics. Octreotide may affect insulin requirement.
Malaysia
